propranolol has been researched along with pirenzepine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Akamatsu, M | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Biggs, DF; Yang, ZJ | 1 |
| Horne, C; Mutschler, E; Palm, D; Pitschner, HF; Schulte, B; Volz-Zang, C; Wellstein, A | 1 |
| Baskin, SI; Thomsen, RH | 1 |
| Jaiswal, N; Malik, KU | 1 |
| O'Donnell, ME | 1 |
| Palm, D; Pitschner, HF; Schlepper, M; Schulte, B; Wellstein, A | 1 |
| Anderson, W; Dickinson, KE; Hirschowitz, BI; Matsumoto, H; Pruitt, RE; Uemura, N | 1 |
| Morrow, C; Murphy, S; Pearce, B | 1 |
| Pitschner, HF; Wellstein, A | 1 |
| Ishii, K; Kato, R | 1 |
| Matsumoto, S | 1 |
| Fleischhacker, WW; Hummer, M; Kohl, C; Kurzthaler, I; Miller, C | 1 |
| Endou, M; Okumura, F; Tanito, Y | 1 |
| García-Sacristán, A; Prieto, D; Simonsen, U; Triguero, D | 1 |
| Fujiwara, Y; Hamamura, T; Kuroda, S; Lee, Y; Ohashi, K; Suzuki, H | 1 |
| Giglio, D; Götrick, B; Tobin, G | 1 |
| Aronsson, P; Eriksson, L; Giglio, D; Tobin, G | 1 |
24 other study(ies) available for propranolol and pirenzepine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Muscarinic-receptor functioning in tracheas from normal and ovalbumin-sensitive guinea pigs.
Topics: Aerosols; Animals; Asthma; Bethanidine; Electric Stimulation; Female; Gallamine Triethiodide; Guinea Pigs; Histamine; Hypersensitivity; In Vitro Techniques; Indomethacin; Methacholine Compounds; Ovalbumin; Pirenzepine; Propranolol; Receptors, Muscarinic; Trachea; Yohimbine | 1991 |
AF-DX 116, a cardioselective muscarinic antagonist in humans: pharmacodynamic and pharmacokinetic properties.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Male; Parasympatholytics; Pirenzepine; Propranolol; Random Allocation; Receptors, Muscarinic; Reference Values; Salivation | 1991 |
The effects of AF-DX 116, a cardioselective muscarinic antagonist, on the negative inotropic action of acetylcholine.
Topics: Acetylcholine; Animals; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Pirenzepine; Propranolol; Rabbits; Rats; Receptors, Muscarinic | 1991 |
Prostaglandin synthesis elicited by cholinergic stimuli is mediated by activation of M2 muscarinic receptors in rabbit heart.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Animals; Arachidonic Acid; Arachidonic Acids; Arecoline; Heart; Heart Rate; Hexamethonium Compounds; Indomethacin; Male; Myocardium; Phentolamine; Pirenzepine; Propranolol; Prostaglandins; Rabbits; Receptors, Muscarinic | 1988 |
Regulation of Na-K-Cl cotransport in endothelial cells by atrial natriuretic factor.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Biological Transport; Cattle; Cells, Cultured; Chlorides; Cimetidine; Cyclic GMP; Endothelium, Vascular; Histamine; Kinetics; Norepinephrine; Pirenzepine; Potassium; Propranolol; Receptors, Adrenergic, beta; Receptors, Histamine H2; Receptors, Muscarinic; Second Messenger Systems; Sodium | 1989 |
AF-DX 116 discriminates heart from gland M2-cholinoceptors in man.
Topics: Adult; Animals; Atropine; Blood Pressure; Cattle; Cell Membrane; Cerebral Cortex; Heart Rate; Humans; Kinetics; Male; Myocardium; N-Methylscopolamine; Organ Specificity; Pirenzepine; Propranolol; Receptors, Cholinergic; Reference Values; Saliva; Salivary Glands; Scopolamine Derivatives; Swine | 1989 |
Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
Topics: Acetylcholine; Animals; Atropine; Bethanechol; Bethanechol Compounds; Carbachol; Esophagus; Imipramine; Kinetics; N-Methylscopolamine; Oxotremorine; Pepsinogens; Pirenzepine; Propranolol; Radioligand Assay; Rana catesbeiana; Receptors, Muscarinic; Scopolamine Derivatives | 1988 |
Astrocytes have both M1 and M2 muscarinic receptor subtypes.
Topics: Animals; Astrocytes; Atropine; Benzodiazepinones; Carbachol; Cyclic AMP; Inositol; Isoproterenol; Phospholipids; Pirenzepine; Propranolol; Rats; Receptors, Muscarinic | 1986 |
Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors.
Topics: Adult; Animals; Atropine; Cattle; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Female; Half-Life; Heart Rate; Humans; In Vitro Techniques; Male; Pirenzepine; Propranolol; Rats; Receptors, Cholinergic; Salivary Glands; Salivation | 1988 |
Suppression by muscarinic M2 stimulation of the contractile mechanism via histamine H1 receptors in the longitudinal muscle of guinea pig ileum.
Topics: Animals; Atropine; Calcium; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine; Ileum; Male; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Phentolamine; Pirenzepine; Propranolol; Pyrilamine; Receptors, Histamine; Receptors, Histamine H1; Temperature; Tetrodotoxin | 1987 |
Functional evidence of excitatory M1 receptors in the rabbit airway.
Topics: Acetylcholine; Animals; Atropine; Bronchoconstriction; Female; Gallamine Triethiodide; Male; Mechanoreceptors; Pirenzepine; Propranolol; Rabbits; Receptor, Muscarinic M1; Receptors, Muscarinic; Vagus Nerve | 1997 |
Propranolol treatment of olanzapine-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Infant; Olanzapine; Pirenzepine; Propranolol; Schizophrenia, Paranoid | 1997 |
A comparison between chronotropic effects of neostigmine and edrophonium in isolated guinea pig right atrium.
Topics: Acetylcholine; Adenosine; Animals; Cholinesterase Inhibitors; Edrophonium; Electric Stimulation; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Neostigmine; Pirenzepine; Propranolol; Tetrodotoxin | 1997 |
Cholinergic modulation of non-adrenergic, non-cholinergic relaxation in isolated, small coronary arteries from lambs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholinesterase; Adrenergic alpha-Antagonists; Animals; Capsaicin; Choline O-Acetyltransferase; Coronary Vessels; Electric Stimulation; In Vitro Techniques; Microcirculation; Myography; Norepinephrine; Phentolamine; Physostigmine; Pirenzepine; Propranolol; Sheep; Suramin; Vasoconstrictor Agents; Vasodilation | 1999 |
Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Benzodiazepines; Cell Count; Cell Nucleus; Clozapine; Locus Coeruleus; Male; Neurons; Olanzapine; Pirenzepine; Prefrontal Cortex; Propranolol; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2000 |
Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Anesthesia; Animals; Blood Pressure; Diamines; Dose-Response Relationship, Drug; Drug Interactions; Female; Muscarinic Antagonists; Parotid Gland; Phentolamine; Piperidines; Pirenzepine; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Receptors, Muscarinic; Saliva; Salivary Glands; Sublingual Gland; Submandibular Gland; Vasodilator Agents | 2002 |
In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cyclophosphamide; Cystitis; Diamines; Electric Stimulation; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Phentolamine; Piperidines; Pirenzepine; Propranolol; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Suramin; Sympatholytics; Urinary Bladder | 2007 |